Placeholder Banner

BIO Signs Coalition Letter In Support of the IGNITE American Innovation Act

August 5, 2020

We write as a coalition of advocates for the startup ecosystem to voice our strong support for the IGNITE American Innovation Act, legislation to support startups through the economic crisis by allowing companies to monetize tax assets generated through a focus on researching and producing products and technologies that create long-term value. Your legislation is by far the most significant proposal under consideration to provide liquidity to startups and sustain critical economic activity that will pay long-term dividends to American workers and the economy. We commend your strong leadership during this crisis and look forward to working with you to include the IGNITE American Innovation Act in an upcoming economic recovery package.

Download Full Comments Below
BIO Signs Coalition Letter In Support of the IGNITE American Innovation Act
Discover More
The following letter provides BIO’s feedback on a number of regulatory proposals by the Centers for Medicare & Medicaid Services that would ease barriers to use of value-based purchasing arrangements within Medicaid and commercial plans, broaden…
The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to submit comments on the Draft Guidance for Industry “Interpreting Sameness of Gene Therapy Products Under the Orphan Drug…
April 12, 2020   Re: Docket No. FDA–2019-D-5585: FDA Draft Guidance, Bridging for Drug-Device and Biologic-Device Combination Products.   Dear Sir/Madam: The Biotechnology Innovation Organization (BIO) thanks the Food and Drug…